Mean N St Dev P value
p53 extension t0 2.71 7 0.488 0.604
  t1 2.86 7 0.378  
p53 intensity t0 2.14 7 1.069 0.689
  t1 2 7 1  
bcl2 int t0 1.14 7 1.215 0.604
  t1 0.86 7 0.378  
bcl2 loc t0 1 7 1 0.604
  t1 1.29 7 0.756  
bcl2 ext t0 1 5 0.707 0.704
  t1 0.8 5 0.447  
p16 foc t0 0.86 7 0.378 0.604
  t1 0.71 7 0.488  
p16 basal t0 0.86 7 1.069 0.356
  t1 0.43 7 0.535  
p16 suprabasal t0 0.86 7 0.9 0.522
  t1 0.57 7 0.535  
ki67 t0 1.86 7 1.215 0.321
  t1 1.29 7 1.38  
p27 basal t0 0 6 0 -
  t1 0 6 0  
p27 suprabasal t0 0.5 4 1 1
  t1 0.5 4 1  
p27 upper t0 2 4 0.816 1
  t1 2 4 0.816  
PCNA basal t0 2.67 6 0.516 0.076
  t1 2.17 6 0.408  
PCNA suprabasal t0 2.83 6 0.408 0.296
  t1 2.33 6 0.816  
p21 basal t0 0.5 6 0.548 0.363
  t1 0.17 6 0.408  
p21 suprabasal t0 2.17 6 0.408 0.042
  t1 1.33 6 0.816  
Table 3b: Immunohistochemistry scores before and after 4 weeks of treatment with Eryfotona® AK-NMSC.